Business Description
NextGen Biomed Ltd
ISIN : IL0010839301
Description
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.8 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -67.4 | |||||
| 3-Year EPS without NRI Growth Rate | -67.7 | |||||
| 3-Year FCF Growth Rate | -17.3 | |||||
| 3-Year Book Growth Rate | 86.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.09 | |||||
| 9-Day RSI | 53.6 | |||||
| 14-Day RSI | 52.42 | |||||
| 6-1 Month Momentum % | -45.84 | |||||
| 12-1 Month Momentum % | -71.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 2.02 | |||||
| Cash Ratio | 1.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.3 | |||||
| Shareholder Yield % | -1.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -64.78 | |||||
| ROA % | -54.25 | |||||
| ROIC % | -33.35 | |||||
| ROC (Joel Greenblatt) % | -119880 | |||||
| ROCE % | -58.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.8 | |||||
| Price-to-Tangible-Book | 0.96 | |||||
| EV-to-EBIT | -0.65 | |||||
| EV-to-EBITDA | -0.65 | |||||
| EV-to-FCF | -1.43 | |||||
| Price-to-Net-Current-Asset-Value | 56.9 | |||||
| Earnings Yield (Greenblatt) % | -152.67 | |||||
| FCF Yield % | -46.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NextGen Biomed Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | |||
| EPS (TTM) (₪) | -2.691 | ||
| Beta | 0 | ||
| Volatility % | 33.51 | ||
| 14-Day RSI | 52.42 | ||
| 14-Day ATR (₪) | 0.12439 | ||
| 20-Day SMA (₪) | 1.12095 | ||
| 12-1 Month Momentum % | -71.32 | ||
| 52-Week Range (₪) | 0.95 - 3.719999 | ||
| Shares Outstanding (Mil) | 7.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NextGen Biomed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NextGen Biomed Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
NextGen Biomed Ltd Frequently Asked Questions
What is NextGen Biomed Ltd(XTAE:NXGN)'s stock price today?
The current price of XTAE:NXGN is ₪1.14. The 52 week high of XTAE:NXGN is ₪3.72 and 52 week low is ₪0.95.
When is next earnings date of NextGen Biomed Ltd(XTAE:NXGN)?
The next earnings date of NextGen Biomed Ltd(XTAE:NXGN) is .
Does NextGen Biomed Ltd(XTAE:NXGN) pay dividends? If so, how much?
NextGen Biomed Ltd(XTAE:NXGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers